X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Cy3-AffiniPure Goat Anti-Mouse IgG (H+L) (min X Hu,Bov,Hrs,Rb,Sw Sr Prot) antibody

RRID:AB_2338690

Antibody ID

AB_2338690

Target Antigen

Mouse IgG (H+L)

Proper Citation

(Jackson ImmunoResearch Labs Cat# 115-165-146, RRID:AB_2338690)

Clonality

polyclonal antibody

Comments

Originating manufacturer of this product

Vendor

Jackson ImmunoResearch Labs Go To Vendor

Cat Num

115-165-146

Publications that use this research resource

APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway.

  • Saito-Diaz K
  • Dev. Cell
  • 2018 Mar 12

Literature context: at#115-165-146; RRID:AB_2338690 Hoechst 33342 ThermoFisher Cat#


Abstract:

Adenomatous polyposis coli (APC) mutations cause Wnt pathway activation in human cancers. Current models for APC action emphasize its role in promoting β-catenin degradation downstream of Wnt receptors. Unexpectedly, we find that blocking Wnt receptor activity in APC-deficient cells inhibits Wnt signaling independently of Wnt ligand. We also show that inducible loss of APC is rapidly followed by Wnt receptor activation and increased β-catenin levels. In contrast, APC2 loss does not promote receptor activation. We show that APC exists in a complex with clathrin and that Wnt pathway activation in APC-deficient cells requires clathrin-mediated endocytosis. Finally, we demonstrate conservation of this mechanism in Drosophila intestinal stem cells. We propose a model in which APC and APC2 function to promote β-catenin degradation, and APC also acts as a molecular "gatekeeper" to block receptor activation via the clathrin pathway.

Funding information:
  • BLRD VA - I01 BX001426()
  • NCATS NIH HHS - UL1 TR000445()
  • NCATS NIH HHS - UL1 TR002243()
  • NCI NIH HHS - P30 CA068485()
  • NCI NIH HHS - P50 CA095103()
  • NCI NIH HHS - R01 CA069457()
  • NCI NIH HHS - R01 CA105038()
  • NIDDK NIH HHS - F30 DK111107()
  • NIDDK NIH HHS - R01 DK099204()
  • NIGMS NIH HHS - R01 GM081635()
  • NIGMS NIH HHS - R01 GM103926()
  • NIGMS NIH HHS - R01 GM106720()
  • NIGMS NIH HHS - R01 GM121421()
  • NIGMS NIH HHS - R01 GM122222()
  • NIGMS NIH HHS - R35 GM122516()
  • NIGMS NIH HHS - T32 GM007347()
  • NIH HHS - OD008466(United States)
  • NIH HHS - P40 OD018537()

Movement maintains forebrain neurogenesis via peripheral neural feedback in larval zebrafish.

  • Hall ZJ
  • Elife
  • 2018 Mar 12

Literature context: rove, Pennsylvania 115-165-146; RRID:AB_2338690 Antibody Cy3-conjugated goat an


Abstract:

The postembryonic brain exhibits experience-dependent development, in which sensory experience guides normal brain growth. This neuroplasticity is thought to occur primarily through structural and functional changes in pre-existing neurons. Whether neurogenesis also mediates the effects of experience on brain growth is unclear. Here, we characterized the importance of motor experience on postembryonic neurogenesis in larval zebrafish. We found that movement maintains an expanded pool of forebrain neural precursors by promoting progenitor self-renewal over the production of neurons. Physical cues associated with swimming (bodily movement) increase neurogenesis and these cues appear to be conveyed by dorsal root ganglia (DRG) in the zebrafish body: DRG-deficient larvae exhibit attenuated neurogenic responses to movement and targeted photoactivation of DRG in immobilized larvae expands the pallial pool of proliferative cells. Our results demonstrate the importance of movement in neurogenic brain growth and reveal a fundamental sensorimotor association that may couple early motor and brain development.

Funding information:
  • Biotechnology and Biological Sciences Research Council - (United Kingdom)
  • Natural Sciences and Engineering Research Council of Canada - Discovery grant (RGPIN-2016-06325)()
  • Natural Sciences and Engineering Research Council of Canada - Post-doctoral fellowship (PDF 454019-2014)()

Stable Positioning of Unc13 Restricts Synaptic Vesicle Fusion to Defined Release Sites to Promote Synchronous Neurotransmission.

  • Reddy-Alla S
  • Neuron
  • 2017 Sep 13

Literature context: unoResearch Cat# 115-165-146, RRID:AB_2338690 Goat ant-rabbit-Cy5 Jackson Imm


Abstract:

Neural information processing depends on precisely timed, Ca2+-activated synaptic vesicle exocytosis from release sites within active zones (AZs), but molecular details are unknown. Here, we identify that the (M)Unc13-family member Unc13A generates release sites and show the physiological relevance of their restrictive AZ targeting. Super-resolution and intravital imaging of Drosophila neuromuscular junctions revealed that (unlike the other release factors Unc18 and Syntaxin-1A) Unc13A was stably and precisely positioned at AZs. Local Unc13A levels predicted single AZ activity. Different Unc13A portions selectively affected release site number, position, and functionality. An N-terminal fragment stably localized to AZs, displaced endogenous Unc13A, and reduced the number of release sites, while a C-terminal fragment generated excessive sites at atypical locations, resulting in reduced and delayed evoked transmission that displayed excessive facilitation. Thus, release site generation by the Unc13A C terminus and their specific AZ localization via the N terminus ensure efficient transmission and prevent ectopic, temporally imprecise release.

Role of AMPA receptors in homocysteine-NMDA receptor-induced crosstalk between ERK and p38 MAPK.

  • Poddar R
  • J. Neurochem.
  • 2017 Aug 25

Literature context: antibody (RRID:AB_2338690) was purch


Abstract:

Homocysteine, a metabolite of the methionine cycle has been reported to play a role in neurotoxicity through activation of N-methyl-d-aspartate receptors (NMDAR)-mediated signaling pathway. The proposed mechanisms associated with homocysteine-NMDAR-induced neurotoxicity involve a unique signaling pathway that triggers a crosstalk between extracellular signal-regulated kinase (ERK) and p38 MAPKs, where activation of p38 MAPK is downstream of and dependent on ERK MAPK. However, the molecular basis of the ERK MAPK-mediated p38 MAPK activation is not understood. This study investigates whether α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) play a role in facilitating the ERK MAPK-mediated p38 MAPK activation. Using surface biotinylation and immunoblotting approaches we show that treatment with homocysteine leads to a decrease in surface expression of GluA2-AMPAR subunit in neurons, but have no effect on the surface expression of GluA1-AMPAR subunit. Inhibition of NMDAR activation with D-AP5 or ERK MAPK phosphorylation with PD98059 attenuates homocysteine-induced decrease in surface expression of GluA2-AMPAR subunit. The decrease in surface expression of GluA2-AMPAR subunit is associated with p38 MAPK phosphorylation, which is inhibited by 1-napthyl acetyl spermine trihydrochloride (NASPM), a selective antagonist of GluA2-lacking Ca2+ -permeable AMPARs. These results suggest that homocysteine-NMDAR-mediated ERK MAPK phosphorylation leads to a decrease in surface expression of GluA2-AMPAR subunit resulting in Ca2+ influx through the GluA2-lacking Ca2+ -permeable AMPARs and p38 MAPK phosphorylation. Cell death assays further show that inhibition of AMPAR activity with 2,3-dioxo-6-nitro-1,2,3,4,tetrahydrobenzoquinoxaline-7-sulfonamide (NBQX)/6-cyano-7-nitroquinoxaline-2,3, -dione (CNQX) or GluA2-lacking Ca2+ -permeable AMPAR activity with NASPM attenuates homocysteine-induced neurotoxicity. We have identified an important mechanism involved in homocysteine-induced neurotoxicity that highlights the intermediary role of GluA2-lacking Ca2+ -permeable AMPARs in the crosstalk between ERK and p38 MAPKs.